Navigation Links
Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
Date:9/19/2007

First in the Industry to Offer Two-Way American Sign Language Support

WASHINGTON, Sept. 19 /PRNewswire/ -- Customers in the Mid-Atlantic region who are deaf or hard of hearing can now communicate directly with Verizon about their services, using videophones and American Sign Language.

The new option for engaging Verizon's Center for Customers with Disabilities is available here and in Maryland, Virginia and West Virginia. Customers can communicate directly via videophone with representatives in the Verizon center who are proficient in using American Sign Language (ASL) to handle orders, change services or answer questions.

[Note: View a video demonstration and recorded comments from a key advocate at http://mfile.akamai.com/14177/wmv/verizon.download.akamai.com/14177/media/v z_v ideo_link.wmv ]

Most video services for people who are deaf or hard of hearing involve an interpreter who relays messages between those individuals and the hearing parties they communicate with. A videophone with a high-speed connection and a monitor, used either one-on-one or with an interpreter, is preferred by many American Sign Language users when they want to communicate by telephone.

"This unique, all-video call center capability lets these customers communicate directly --- in their preferred language, in real time -- with a Verizon customer service representative who can engage in conversation using ASL," said Tom Boudrow, who is outreach manager at the Verizon Center for Customers with Disabilities and who is deaf.

"Verizon is the first company in the industry to offer customer service via videophone - another example of our leadership position in providing effective communications for all of our customers and our quest to make the center a valued resource for customers with disabilities."

Claude Stout, executive director of Telecom
'/>"/>

SOURCE Verizon
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008).../ -- The Providence Service,Corporation (Nasdaq: ... Company,s,Chief Operating Officer, has been appo...orris, appointment fills the vacancy left by the A...eturns the board to six members. Mr.,Norris will... Mr. Norris, age 41, has been with Providence sinc...
(Date:11/21/2008)...que to combat cancer, study says, , ,...rchers have discovered that some cancer cells use ...ght lead to new treatments that starve and kill th...lls in the body need to produce energy. They do th...ires oxygen. Compared with normal cells, tumor cel...
(Date:11/21/2008)...ect Investment And Restore Shareholder Value , ...-- Dr. Stephen Joffe, Craig Joffe, and Alan Buckey...th the U.S. Securities and Exchange Commission. T...ip of 11.4% of LCA-Vision, Inc. (Nasdaq: LCAV ),...on correction centers in 33 states in the United S...
(Date:11/21/2008)...l/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL ) to... approved the proposals submitted to them relating...s Industries Ltd. (Nasdaq: TEVA ). , , "... of the transaction by the Barr shareholders," sai...e pleased with the progress that we continue to ma...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
... year received gifts for Christmas that may result...ly confine children to their houses and thereby ma...t Wales Institute of Higher Education (NEWI) revea...kids. X-mas gifts fail to encourage children to go...
...nne Murabito and team have reported that the risk ...ho have their siblings with heart disease.// Thoug...t disease is genetically susceptible and risk incr...dy has shown a 45% increased risk of heart disease...
...ng comes a study that states that about one-third ...o 49 years) in the U.S. have poor cardio respirato...holesterol and blood pressure levels. The study is...JAMA. There has been a strong correlation betwee...
...on children’s will be hi-tech whiz kids but would ...o indoor games with no physical activity.// A surv...er Education found that there is an increase in ob...nd poor diet rich in fatty foods due to fast food....
Other Medicine News:
(Date:11/20/2008)...swire-FirstCall/ -- Duska Therapeutics,Inc., (OT...as submitted its,pivotal Phase 3 ATPace clinical ...l Assessment (SPA) procedure with the U.S. Food an...securing an agreement with the FDA, Duska intends ...placebo-controlled and randomized Phase 3,clinica...
(Date:11/20/2008)...tCall/ -- PAREXEL International Corporation (Nasda...rvices provider, today announced that it has opene...nsulting and clinical research capabilities. With ...ocations throughout five important biopharmaceutic...gentina, Brazil, Chile, and Mexico. This expansion...
(Date:11/19/2008)...PRNewswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) ...sidiary of,Takeda Pharmaceutical Company Limited ...he Phase 3 MONET1 trial evaluating motesanib (AMG ...in for the first-line treatment of,advanced non-s... suspended,following a planned safety data review...
(Date:11/19/2008)...ewswire/ -- Biotech scientists increasingly are ap...h to better understand the effects of novel drug c...Genetic Engineering & Biotechnology News ( GE...t a new compound,s mechanism of action and eventua...according to the November 15 issue of GEN . ( htt...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7GEN Reports on the Trend Toward Predictive Toxicogenomics 2World Famous DavidBartonGym Buffs up the Bravern 12788 1World Famous DavidBartonGym Buffs up the Bravern 12788 2World Famous DavidBartonGym Buffs up the Bravern 12788 3Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 1Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 2Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 3Implementers Advocates Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology 12785 4Plexus Systems Inc Names Stosz to Solutions Engineer 12783 1Plexus Systems Inc Names Stosz to Solutions Engineer 12783 2Plexus Systems Inc Names Khanna to Senior Account Manager Western Region 12779 1Plexus Systems Inc Names Khanna to Senior Account Manager Western Region 12779 2
...INESS WIRE)--Apr 19, 2007 - Othera Pharmaceuticals...essor of,Pharmacology and Executive Vice President...tute at Albany College of Pharmacy,will present n...ombotic effect of Othera,s lead compound, OT-551, ... previous ocular,studies on OT-551 eye drops, as w...
..., April 19, 2007 /PRNewswire-FirstCall/ --,CuraGen...at,preliminary interim clinical data on intravenou...) inhibitor being investigated,for the treatment o...ming major medical meetings. , One oral and one po...lts with belinostat will be made at the 2007 Ameri...
Other Medicine Technology:Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 2Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 3Othera Pharmaceuticals Announces Upcoming Presentation Based Upon,Expanded Understanding of Lead Compound Mechanism of Action 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5
Wet-Field Hemostatic Eraser bipolar tip, packsize is 5/box.
Sterile cordless eraser tips, packsize is 10/box.
Hydroview insertion forcep with very thin jaws to allow insertion through tunnel or clear cornea incision. Locking. Made in titanium.
Bi-angled insertion jaws designed to enhance surgeon comfort and efficiency. Reverse action releases lens when handle is compressed. Made in titanium.
Medicine Products: